Royal Marsden Joins AI Revolution with New Radiology Analysis to Transform Cancer Research
May 27, 2025
Research will utilize anonymized data in collaboration with the Institute of Cancer Research to assess the accuracy and efficiency of AI tools in a clinical research setting.
Tom Winstanley, CTO at NTT DATA, praised the initiative as a responsible innovation that showcases the ethical application of AI in healthcare.
Health Minister Karin Smyth emphasized that this collaboration is part of the NHS's modernization efforts, aligning with the 10 Year Health Plan to enhance healthcare through digital innovations.
In a related development, Evariste, an AI-driven drug discovery company, recently partnered with the University of Southampton to create a large transcriptomic dataset for esophageal adenocarcinoma, further showcasing advancements in cancer research.
The service operates on a specialized MLOps clinical imaging platform developed by NTT DATA, featuring high-performance Dell servers and advanced GPU processing capabilities managed by CARPL.ai.
This service includes tools for monitoring the performance of AI models over time, streamlining the development and evaluation process.
The Royal Marsden is recognized as one of the leading cancer research centers globally, established in 1851 and operating in partnership with the Institute of Cancer Research.
The Royal Marsden NHS Foundation Trust has teamed up with NTT DATA and CARPL.ai to introduce an AI-powered radiology analysis service aimed at advancing cancer research.
Professor Dow-Mu Koh highlighted the project's potential to transform cancer diagnosis and treatment, creating a scalable research environment that could significantly improve patient care.
CARPL.ai's platform will facilitate the management and testing of various radiology AI models, providing essential access for evaluation.
The primary goal is to create a controlled environment for rigorous testing of AI models, allowing for thorough evaluation before any deployment in patient care.
The centralized interface from CARPL.ai will enable real-time monitoring of AI model performance, establishing faster feedback loops crucial for clinical application.
Summary based on 15 sources



